News

Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...
The prevalence of food allergy is significantly lower in children with cystic fibrosis than in those without the condition in ...
With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis ...
Two brothers and two friends take on and wi, an 80-mile Atlantic paddleboard challenge in an effort to provide support for ...
Most children with CF treated at a San Francisco CF clinic did not receive CF liver disease screening in accordance with current guidelines.
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® ...
Cairns Funeral Directors' chapel at Manoora was overflowing with people attending the funeral service of cystic fibrosis ...
Vertex Pharmaceuticals (VRTX) on Tuesday announced that the European Commission has granted approval for Alyftrek for the ...
Ben is running 12 marathons in 12 months to raise awareness for cystic fibrosis, a condition he's battled since childhood.
A family who know how devastating a cystic fibrosis diagnosis can be recently tackled an assault course in support of poorly ...
Microbiome-directed therapy for cystic fibrosis exacerbations currently fails to improve lung function and may increase ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...